Clinical Drug Experience Knowledgebase

Anxiety Disorders (Phase 4)

Atherosclerosis (Phase 4)

Brain Injuries (Phase 3)

Cerebral Infarction (Phase 3)

Cognition Disorders (Phase 3)

Cognitive Dysfunction (Phase 3)

Communicable Diseases (Phase 4)

Developmental Disabilities (Phase 3)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Dyspepsia (Phase 4)

Glucose Intolerance (Phase 3)

Hyperplasia (Phase 3)

Infections (Phase 4)

Influenza, Human (Phase 4)

Intracranial Arteriosclerosis (Phase 4)

Ischemia (Phase 3)

Learning Disabilities (Phase 3)

Lung Diseases (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Neurotic Disorders (Phase 4)

Prostatic Hyperplasia (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Respiratory Tract Infections (Phase 3)

Stroke (Phase 3)

Trematode Infections (Phase 4)

Virus Diseases (Phase 4)

Wounds and Injuries (Phase 3)